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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S167Methods: This cross-sectional study includes members of the Fra-
mingham Foot Study. A validated exam of the foot was used to assess
the presence of hallux valgus, hallux rigidus, and plantar fasciitis. To
determine foot type, center of pressure excursion index (CPEI)
measurements were recorded using the TekScan Matscan (1.4 sensors/
cm2) system. CPEI is a dynamic measure of foot type that uses the
concavity of the center of pressure curve in the metatarsal head region,
normalized to foot width during the stance phase of gait. In a prior
study by Hillstrom et al., utilizing the emed-x plantar pressure system
(4 sensors/cm2), CPEI thresholds discriminated planus, rectus (normal
arch), and cavus (high arch) feet. Due to the differences in system
resolution, a scaling equation was developed in order to determine the
equivalent CPEI threshold on a TekScan Matscan system that differen-
tiated planus from non-planus (rectus and cavus) feet. This threshold
was deﬁned as a CPEI19.4% on a TekScan Matscan system. Crude and
adjusted logistic regression models, using generalized estimating
equations (GEE) to account for the correlation between left and right
feet, were used to calculate odds ratios for the relation between foot
type and the prevalence of hallux rigidus, hallux valgus, and plantar
fasciitis. Adjusted models included age, sex and body mass index (BMI).
Results: This study included 2,994 participants (5,778 feet) with an age
range of 36-98 years and 55% women. The results are shown in Table 1.
Approximately 74% of the study population (mean age¼65.59.9 years)
was classiﬁed as having pes planus in at least one foot. Those with ﬂat
feet were at an increased odds for hallux valgus (OR 1.6, 95% CI 1.4, 1.8)
and hallux rigidus (OR 1.6, 95% CI 1.1, 2.3). These results remained
signiﬁcant when adjusted for age, gender, and BMI.
Conclusions: Those with planus foot type had a higher odds of hallux
valgus and hallux rigidus, but not plantar fasciitis. The high prevalence
rate of pes planus in the Framingham cohort may be because the
average participant is 66 years old and arch height has been shown to
decrease with age. Further, CPEI recordings may be more sensitive to
less severe cases of pes planus, contributing to this high prevalence rate.
Hallux valgus and hallux rigidus was more prevalent in pes planus
versus non-planus feet. This is important because foot structure and
function are potentially modiﬁable factors for these pathologies that
have implications for prevention and treatment.Results from GEE logistic regression models assessing the odds of
foot pathology.
Hallux Valgus Hallux Rigidus Plantar Fasciitis
Prevalence (%) 49.6 5.9 6.6
Foot Type n (%) n (%) n (%)
Planus (CPEI19.4%) 29.1 3.6 3.2
Non-Planus (CPEI>19.4%) 20.5 2.3 3.4
Bivariate Model
(N¼5,781)
OR (95%CI) OR (95%CI) OR (95% CI)
Foot Type
Planus (CPEI19.4%) 1.6 (1.4-1.8) 1.6 (1.1-2.3) 0.97 (0.70-1.3)
Non-Planus
(CPEI>19.4%)
Ref Ref Ref
Hallux Valgus Hallux Rigidus Plantar Fasciitis
Multivariate
Model (N¼5,781)*
OR (95%CI) OR (95%CI) OR (95%CI)
Foot Type
Planus (CPEI19.4%) 1.2 (1.1-1.4) 1.5 (1.1-1.9) 0.89 (0.67-1.2)
Non-Planus (CPEI>19.4%) Ref Ref Ref
* Adjusted for age, gender, & BMI317
SURVIVAL ON CONTROLLED-RELEASE MORPHINE VERSUS
CONTROLLED-RELEASE OXYCODONE IN OPIOID-NAÏVE PATIENTS
WITH NON-MALIGNANT PAIN: DATA FROM DANISH NATIONAL
HEALTH REGISTERS
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Vestergaard z. yMusculoskeletal Statistics Unit, the Parker Inst., Dept. of
Rheumatology; Copenhagen Univ. Hosp., Frederiksberg, Copenhagen,
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Purpose: Opioids provide one treatment option for severe non-cancer
pain. In osteoarthritis the beneﬁts associated with the use of opioids arepresumably limited by frequent side effects, leading patients to with-
draw, switch/rotate to another opioid. The aim of this study was to
compare the risk of patients rotating opioid therapy from either
controlled-release (CR) morphine or CR oxycodone in opioid-naïve
patients with non-malignant pain.
Methods: By individual-level linkage of the Danish nationwide
administrative registries between 2005-2007, adult patients who were
prescribed either CR morphine or CR oxycodone, who had not previ-
ously been prescribed opioids (at least six months prior to “baseline”
deﬁned as the ﬁrst prescription of CR morphine or CR oxycodone), were
followed up for as long as 3 years (maximally until December 31, 2007).
Patients with a cancer diagnosis were excluded from the study and
subsequent analyses. Adjusted for age, sex, comorbidity, calendar year,
concomitant pharmacotherapy, income and social status, Hazard Ratios
(HR) for the association between opioid treatment (CR-oxycodone vs.
CR-morphine) and withdrawal from opioid therapy were analyzed by
Cox proportional-hazard models. The main outcome measure was the
number of patients switching from one type of opioid to another;
secondary outcome was the number of patients who were able to
withdraw from opioid therapy (i.e., no further need for opioid
analgesics).
Results: Of the 101,635 patients assessed for inclusion, 75,587 (74%)
had been prescribed opioids 6 months prior to enrolment and 4,818
(5%) had a cancer diagnosis. In total, 21,230 patients were enrolled,
16,553 (78%) were prescribed CR-oxycodone and 4,677 (22%) CR-
morphine. Of these, 5,750 (35%) CR-oxycodone patients and 2,166
(46%) CR-morphine patients switched to another opioid. After adjust-
ment, CR-oxycodone was associated with a statistically signiﬁcant
reduced risk for rotation (switch) to another opioid compared to CR
morphine; HR ¼ 0.82 (95%CI: 0.78-0.87; P<0.001). Among patients
still on therapy at time of censoring (possible drug addiction devel-
opment), 4.5% (112) were still using CR-morphine and 2.1% (231) were
using CR-oxycodone.
Conclusion: This study demonstrates a signiﬁcantly greater risk (18%)
for opioid rotation using CR-morphine compared with CR-oxycodone in
patients suffering from non-malignant pain.318
SIMULATION MODELING WITH SYSTEM DYNAMICS (SD) TO PLAN
OSTEOARTHRITIS CARE DELIVERY IN ALBERTA
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Purpose: Currently, there are no reliable and validated tools that health
service decision-makers can use to inform system level policy decisions.
To address this need, we worked with health administrators, clinicians
and researchers to create and validate a decision-support tool that
service planners can use to achieve a sustainable, integrated care
system for hip and knee osteoarthritis (OA).
Methods: The tool is based on a system dynamics (SD) model of patient
ﬂow across the continuum of care, including self-directed, primary,
rheumatologic and orthopaedic specialist, acute, and surgical follow-up
care. The model was developed in four phases: phase 1 focused on
demand and ﬂow rates, phase 2 on resource use and costs, phase 3 on
geographical stratiﬁcation, and phase 4 on adding feedback loops. We
populated the model with data from several sources, including Alberta
Health & Wellness (e.g. physician claims, inpatient, and ambulatory
data), Statistics Canada (e.g. the Survey of Living with Chronic Diseases
in Canada and population projections), and the Alberta Bone and Joint
Health Institute (clinical/surgical data). Using established principles of
SD modeling and an iterative, integrated knowledge translation process
involving multiple workshops with front-line clinical staff and admin-
istrators, we deﬁned the problem, determined the care process,
modeled the system as a series of stock and ﬂows, tested, validated and
calibrated the model.
Results:We have developed the full SD model, for two key applications.
First, it can help identify ﬂow, resource use and cost variations in
current practice, which may beneﬁt from further exploration. For
example, variations in practice patterns, particularly surgery rates and
resource use, were observed among the health zones reﬂecting regional
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if’ scenarios that can demonstrate system wide and long-term effects
that may result from changes in care processes. For example, two
scenarios examined were: “What would happen if 1) primary care
providers could manage more patients medically, ultimately referring
fewer patients to specialists; and 2) primary care providers in all health
zones adopted one zone's rheumatologist referral patterns for OA
patients?” Such scenarios change the pathways through which simu-
lated patients ﬂow, the results of which can provide insight into
intended and unintended effects on resource use and costs across the
continuum of care over a lengthy time horizon.
Conclusions: Our SD model can be used as a decision-support tool to
estimate changes in health care demands, resource requirements and
costs over time and as a result of ‘what if’ scenarios. It is critically
important to involve clinicians and decision-makers in the develop-
ment of such tools to ensure they are appropriate representations of the
system and to facilitate their adoption and continued use to inform
decision making.319
QUADRICEPS MUSCLE STRENGTH AND ITS RELATIONSHIP TO
RADIOGRAPHIC KNEE OSTEOARTHRITIS
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Purpose: Knee osteoarthritis (knee OA) is multifactorial disease and
strongly affected by mechanical factors. The aims of the present study
were to develop a lightweight muscle strength measuring device and
investigate the relationship between knee OA and quadriceps muscle
strength by epidemiological survey.
Methods: We developed portable quadriceps muscle training machine
(QTM) and the accuracy of measuring was evaluated. Then, the rela-
tionship between radiographic knee OA and quantitative quadriceps
muscle strength was investigated by epidemiological survey (Matsudai
Knee Osteoarthritis Survey) using this device.
Results: Signiﬁcant correlation was observed between QTM and BIO-
DEX (r¼0.69, 0.82). In Matsudai Knee Osteoarthritis Survey, 2032 knees
in 1016 subjects (482 men and 534 women), average age was 65.913.0
years old, were investigated. The prevalence of radiographic OA (grade
II or higher upon Kellgren-Lawrence classiﬁcation) was: 13%, 36.9%,
67.8%, and 86.5%, regardingwomen in their ﬁfties, sixties, seventies, and
eighties, respectively, and was 1.7%, 13.4%, 33.5%, and 66.2% regarding
men, respectively. Quadriceps muscle strength declined following 50
years of age, and signiﬁcant decline was observed in their sixties and
seventies. Quadriceps muscle strength of OA group (grades II, III and IV)
was signiﬁcantly declined comparing with that of Non-OA group
(grade-0 and I). Furthermore, tendency of the muscle strength level to
decline with the progression of knee OA grade was particularly
observed between grade 0 and grade I in both men and women and
between grade I and grade II in men.
Conclusions: This is the ﬁrst report in Japan that quantitatively eval-
uated the relationship between knee OA and quadriceps muscle
strength in epidemiological survey, and we found the correlation
between knee OA and the decline in quadriceps muscle strength.
Furthermore, it suggests that the decline in quadriceps muscle
strength may be more strongly related to the incidence of knee OA
than its progression.320
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Purpose: Degenerative diseases of the cartilage, such as osteoarthritis,
are age-related. The histone deacetylase Sirt 1 (silent information
regulator 2 homolog 1) is thought to be an anti-aging protein. We
previously demonstrated that Sirt 1 regulates apoptosis and cartilage-speciﬁc gene expression in human chondrocytes. To determine if Sirt 1
plays a protective role in cartilage homeostasis in vivo, we investigated
Sirt 1 KO and Sirt 1mutant mice to characterize their cartilage and try to
understand the mechanisms underlying a phenotype, such as cartilage
breakdown or apoptosis.
Method: Articular cartilage was harvested from hind paws and knees of
1-week to 6-month-old mice carrying wild type, null, or point muta-
tions affecting the Sirt 1 gene. The cartilage was processed for histology
and immunohistochemistry or used to establish cultures of
chondrocytes.
Results: We found that articular cartilage tissue sections from Sirt1 KO
mice and mutant mice, at any age, exhibited low levels of type 2
collagen, aggrecan, and glycosaminoglycans. In contrast, protein levels
of MMP-8, MMP-9, and MMP-13 were elevated in the Sirt1 KO and
mutant mice, leading to an increase of cartilage breakdown. The
apoptotic process was shown to be elevated in these mice. Moreover,
PTP1b (protein tyrosine phosphatase b)_a chondrocyte proapoptotic
protein elevated in OA_was elevated in the Sirt1 KO mice.
Conclusion: The ﬁndings from these animal models demonstrated that
Sirt1 KOmice andmice expressing a mutant allele of Sirt 1 presented an
altered cartilage phenotype. The apoptotic process and the cartilage
breakdown were elevated in these mice.321
NOVEL CANDIDATE GENES FOR STRUCTURAL FOOT DISORDERS:
A GENOME-WIDE ASSOCIATION STUDY IN AN OLDER CAUCASIAN
POPULATION
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Purpose: Structural foot disorders, such as hallux valgus, deformities
of the lesser toes (toes 2-5) and plantar soft-tissue atrophy, commonly
affect w 60% of older adults at the population level and are often
linked with foot pain, chronic mobility limitations, and disability.
Although, body weight and other environmental factors are considered
possible causes of these foot conditions, the importance of genetics is
commonly suspected in clinical observations of family aggregation.
Previously, we reported strong heritability (h2) for lesser-toe deformity
(61% in men; 85% in women) and moderate h2 for hallux valgus
(w35%) and plantar soft-tissue atrophy (w20%) in older men and
women, suggesting potential genetic predisposition to structural foot
disorders. To identify their genetic determinants, we have undertaken
a GWAS using 2.5M imputed SNPs (HapMapII CEU reference panel) to
localize susceptible genes in the population-based Framingham Foot
Study.
Methods: Structural foot disorders were indicated as present or absent
and were assessed based on an atlas of pictorial depictions. Plantar soft
tissue atrophy was determined by palpating the plantar fat pad at the
forefoot and heel during a validated foot examination. Among 2,446
Framingham participants (mean age 66 yrs; 57% women; Caucasian),
we identiﬁed 753 (31%), 764 (31%) and 665 (27%) participants with
deformities of the lesser-toes, hallux valgus and plantar soft-tissue
atrophy, respectively. A mixed-effect regression model was performed
and adjusted for age, sex, weight and principal components of ancestral
genetic background. A kinship covariance matrix was used to take into
account within-family correlations among siblings. We ﬁltered out
SNPs with low imputation quality (O/E variance ratio of allele frequency
< 0.3) and SNPs with MAF < 1%. In addition, p-values were also
adjusted for lGC.
Results: We found several associations achieved genome-wide signiﬁ-
cance (p< 5x10-8), i.e. SNPsonTBC1D22A andOR5D13 gene for lesser-toe
deformity. For hallux valgus, the most signiﬁcant SNP (p¼4.9x10-7) is
located in GATAD2B gene. For plantar soft-tissue atrophy, the most
signiﬁcant SNP (p¼4.76x10-7) is located near ADAMTS16 gene. Pathway
and gene-set analyses for the genome-wide signiﬁcant and suggestive
genes suggested signiﬁcant clustering of genes involved in connective
tissue disorders (such as oligoarticular arthritis, osteoarthritis and
osteosclerosis). Of note, a few SNPs were reported to associate with
longevity. These results are undergoing replication in independent
samples.
Conclusions: In conclusion, our results identify novel candidate genes
to further elucidate the etiology of structural foot disorders.
